Cargando…
Direct and indirect resource use, healthcare costs and work force absence in patients with non‐infectious intermediate, posterior or panuveitis
PURPOSE: To ascertain resource use, costs and risk of workforce absence in non‐infectious uveitis cases versus matched controls. METHODS: In a retrospective claims analysis of employees in the United States, prevalent (N = 705) and incident (N = 776) cases 18–64 years old with ≥2 diagnoses of non‐in...
Autores principales: | Thorne, Jennifer E., Skup, Martha, Tundia, Namita, Macaulay, Dendy, Revol, Cindy, Chao, Jingdong, Joshi, Avani, Dick, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069656/ https://www.ncbi.nlm.nih.gov/pubmed/26932535 http://dx.doi.org/10.1111/aos.12987 |
Ejemplares similares
-
Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names
por: Chao, Jingdong, et al.
Publicado: (2015) -
Intermediate uveitis, posterior uveitis, and panuveitis in the Mid-Atlantic USA
por: Engelhard, Stephanie B, et al.
Publicado: (2015) -
Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018) -
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis
por: Denniston, Alastair K., et al.
Publicado: (2015) -
Noninfectious Intermediate, Posterior, or Panuveitis: Results from the Retrospective, Observational, International EyeCOPE Study
por: Kramer, Michal, et al.
Publicado: (2021)